Russell Investments Group
CLCD

Russell Investments Group’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Russell Investments Group’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-42,998
Closed -$1.58M – 3185
2016
Q4 		$1.58M Buy
+42,998
New +$1.52M ﹤0.01% 1924

Other funds holding CLCD

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Russell Investments Group's CLCD Position: Q1 2017 in Review

Russell Investments Group sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 42,998 shares — an estimated $1.58M sold.

Russell Investments Group first reported a position in CLCD in Q4 2016 and held it in 1 quarter. The position peaked at $1.58M in Q4 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

  • Russell Investments Group reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Russell Investments Group sold 42,998 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $1.58M.
  • Russell Investments Group first reported a position in CoLucid Pharmaceuticals, Inc. in Q4 2016 and held it in 1 quarter.
  • Russell Investments Group's CoLucid Pharmaceuticals, Inc. position peaked at $1.58M in Q4 2016.
  • 1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Russell Investments Group's 13F filing for Q1 2017, filed 26 Apr 2017.